Drug Research

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), entered into a collaborative partnership with ScaleReady, a joint venture between Bio-Techne, Fresenius Kabi and Wilson Wolf that brings together...

Ascend Gene & Cell Therapies, a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for gene therapy technologies, announces  that it has launched as a facilitator for gene therapy companies to help...

nVentic, the inventory optimization specialist, has today launched its 2023 Big Pharma Inventory Benchmarking Report. The report, which analyses the published corporate reports of 28 major pharmaceutical manufacturers, including Merck, AstraZeneca and Pfizer, is an annual look at the...

Researchers have gone on to develop a physics-enhanced autocorrelation-based estimator (PEACE) machine learning algorithm that can go ahead with the extraction of the particle size distribution (PSD) of a pharmaceutical powder surface from its laser spot. The process provides...

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), continues to drive the expansion of capacities and services for the provision of clinical trial materials: With the implementation of additional equipment for aseptic production and the expansion of...

A novel approach within the genetic engineering of cells promises major enhancements when it comes to speed, effectiveness, and reduction in cellular toxicity as compared to the current methods. The approach could also go on to power advanced cell...

For many years, the rising complexity of APIs has led to the development of a sea of novel formulations that help in the efficient delivery of drugs to the intended site where action needs to happen. Nevertheless, the demand...